“[Oil States] explained that the ‘decision to grant a patent is . . . the grant of a public franchise,’…and once a patent expires ‘the public franchise ceases to exist and the patent owner no longer ...

At its core, a patent is a contract between an inventor, who agrees to disclose detailed information about their invention to the public, and the state, which grants them exclusive rights to that ...

The idea of a “patent cliff” wave of exclusivity expirations shaking up the biopharma industry isn’t new: GEN first mentions the term in 2010 and again a year later when Lipitor (atorvastatin) lost ...